title: [Pharmaceutical care program for pediatric patients receiving antiretroviral therapy].
abstract: OBJECTIVE
  To present a pharmaceutical care program for pediatric patients receiving antiretroviral therapy.
  
  
  METHODS
  In order to establish the pharmaceutical care procedure, papers published up to 2004 on the pharmaceutical care provided to patients receiving antiretroviral therapy were reviewed through a search in Medline and the journal Farmacia Hospitalaria. In addition, bibliographic references that can be systematically used to analyze the pharmacotherapy of each patient have been selected.
  
  
  RESULTS
  The pharmaceutical care procedure is divided in three stages (data collection, analysis of the pharmacotherapeutic profile and resolution of the drug-related problems identified) that take place through a semi-structured type of interview. In order to systematize the role of the pharmacist, a table with information on antiretroviral drugs used in Pediatrics was created, as well as an information three-page leaflet and a data collection form.
  
  
  CONCLUSIONS
  The program includes the goals of the pharmaceutical care process as defined in the recommendations of GESIDA-SEFH-National AIDS Plan 2004 and systematizes the proposed intervention strategies, in an attempt to provide the patient and the caregiver with the information required for an optimum management, in the most comprehensive way and tailored to their individual characteristics.
authors.affiliation: Servicio de Farmacia, Hospital General Universitario Gregorio Marañón, C/Dr. Esquerdo 46, 28007 Madrid, Spain. nbarrueco.hgugm@salud.madrid.org
authors.forename: N
authors.initials: N
authors.lastname: Barrueco
authors.forename: I
authors.initials: I
authors.lastname: Castillo
authors.forename: A
authors.initials: A
authors.lastname: Ais
authors.forename: C
authors.initials: C
authors.lastname: Martínez
authors.forename: M
authors.initials: M
authors.lastname: Sanjurjo
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D002648:Child; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010593:Pharmaceutical Services; D016730:Program Development
chemical_list: D044966:Anti-Retroviral Agents